Cryoport is a company that leads the industry in frozen transport for biologic material. They transport tissue samples, blood, and other types of sensitive material for use in labs, pharmaceutical companies, manufacturers, researchers, and reproductive medicine.
When Cryoport (CYRX) went public in March 2005, the stock showed great promise, and they were positioned to really take off in the frozen shipping industry.
They were technologically better than other companies. But, they suffered from inferior management. This caused the stock to drop from it’s initial price of $50.80 per share to a penny stock by 2014.
In 2012, Cryport got a new CEO, who is forming strategic alliances. He is still in place today, as the company continues to find its place in the industry. Want to learn how to recover losses in stock market? Contact us today